2019
DOI: 10.1007/s12029-019-00330-w
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of ROMO1 and OMA1 are Potentially Biomarkers and Predict Unfavorable Prognosis in Gastric Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
22
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(22 citation statements)
references
References 28 publications
0
22
0
Order By: Relevance
“…OMA1, as an ATP‐dependent zinc metalloprotease located in the mitochondrial inner membrane, was previously reported to be activated by self‐cleavage during stress conditions and participate in mitochondrial protein quality control (Käser et al , 2003; Baker et al , 2014; Zhang et al , 2014; Bohovych et al , 2016), and some recent research starts to link the OMA1 expression to gastric cancer initiation and breast cancer metastasis (Amini et al , 2019; Daverey et al , 2019). In our present study, the bioinformatics analyses showed the expression of OMA1 is upregulated in the tumors from colorectal cancer patients and increased OMA1 expression correlates with poor prognosis (Fig 1A and B).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…OMA1, as an ATP‐dependent zinc metalloprotease located in the mitochondrial inner membrane, was previously reported to be activated by self‐cleavage during stress conditions and participate in mitochondrial protein quality control (Käser et al , 2003; Baker et al , 2014; Zhang et al , 2014; Bohovych et al , 2016), and some recent research starts to link the OMA1 expression to gastric cancer initiation and breast cancer metastasis (Amini et al , 2019; Daverey et al , 2019). In our present study, the bioinformatics analyses showed the expression of OMA1 is upregulated in the tumors from colorectal cancer patients and increased OMA1 expression correlates with poor prognosis (Fig 1A and B).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, recent studies revealed another piece of evidence that stress‐activated OMA1 mediates the cleavage of DELE1, which then relays mitochondrial stress to the cytosol (Fessler et al , 2020; Guo et al , 2020). So far, the role of OMA1 in cancer is complicated, depending on the type of cancer, the disease stage, the treatment, and many other factors (Jiang et al , 2014; Alavi, 2019; Amini et al , 2019; Daverey et al , 2019), and the underlying mechanism of OMA1 in regulating tumorigenesis and progression remains largely unknown.…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, ROC curve analysis suggested that ROMO1 could be considered as a potential tumor marker for bladder cancer. ROMO1 has shown to be a potential biomarker in cancer and anticipate unfavorable prognosis in cancer [27]. Finally, it can be concluded that this important mitochondrial protein can predispose individuals to develop bladder cancer, thereby increasing the level of free radical agents.…”
Section: Discussionmentioning
confidence: 97%
“…Recently, Amini and colleagues have found that increased expression of ROMO1 plays an essential role in the growth and development of gastric cancer [27]. Several lines of evidence demonstrated that increased expression of ROMO1 and oxidative stress are positively correlated to different pathologic conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Most patients with gastric cancer are identi ed in advanced stages of the disease. Although speci c diagnostic and treatment methods for gastric cancer have been used, the survival rate of these patients is about 5 years, which is a very low survival rate [3][4][5][6][7]. Today, certain tumor markers are used such as CA19-9 and carcinoma embryonic antigen (CEA) to diagnose gastric cancer, but they have no speci city to diagnose this malignancy [8].…”
Section: Introductionmentioning
confidence: 99%